Tranexamic acid and trauma: Current status and knowledge gaps with recommended research priorities

Anthony E. Pusateri, Richard B. Weiskopf, Vikhyat Bebarta, Frank Butler, Ramon F. Cestero, Irshad H. Chaudry, Virgil Deal, Warren C. Dorlac, Robert T. Gerhardt, Michael B. Given, Dan R. Hansen, W. Keith Hoots, Harvey G. Klein, Victor W. MacDonald, Kenneth L. Mattox, Rodney A. Michael, Jon Mogford, Elizabeth A. Montcalm-Smith, Debra M. Niemeyer, W. Keith PrusaczykJoseph F. Rappold, Todd Rassmussen, Francisco Rentas, James Ross, Christopher Thompson, Leo D. Tucker

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

A recent large civilian randomized controlled trial on the use of tranexamic acid (TXA) for trauma reported important survival benefits. Subsequently, successful use of TXA for combat casualties in Afghanistan was also reported. As a result of these promising studies, there has been growing interest in the use of TXA for trauma. Potential adverse effects of TXA have also been reported. A US Department of Defense committee conducted a review and assessment of knowledge gaps and research requirements regarding the use of TXA for the treatment of casualties that have experienced traumatic hemorrhage. We present identified knowledge gaps and associated research priorities. We believe that important knowledge gaps exist and that a targeted, prioritized research effort will contribute to the refinement of practice guidelines over time.

Original languageEnglish (US)
Pages (from-to)121-126
Number of pages6
JournalShock
Volume39
Issue number2
DOIs
StatePublished - Feb 2013
Externally publishedYes

Fingerprint

Tranexamic Acid
Wounds and Injuries
Research
United States Department of Defense
Afghanistan
Practice Guidelines
Randomized Controlled Trials
Hemorrhage

Keywords

  • efficacy
  • research requirements
  • safety
  • Tranexamic acid
  • trauma

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Emergency Medicine

Cite this

Pusateri, A. E., Weiskopf, R. B., Bebarta, V., Butler, F., Cestero, R. F., Chaudry, I. H., ... Tucker, L. D. (2013). Tranexamic acid and trauma: Current status and knowledge gaps with recommended research priorities. Shock, 39(2), 121-126. https://doi.org/10.1097/SHK.0b013e318280409a

Tranexamic acid and trauma : Current status and knowledge gaps with recommended research priorities. / Pusateri, Anthony E.; Weiskopf, Richard B.; Bebarta, Vikhyat; Butler, Frank; Cestero, Ramon F.; Chaudry, Irshad H.; Deal, Virgil; Dorlac, Warren C.; Gerhardt, Robert T.; Given, Michael B.; Hansen, Dan R.; Hoots, W. Keith; Klein, Harvey G.; MacDonald, Victor W.; Mattox, Kenneth L.; Michael, Rodney A.; Mogford, Jon; Montcalm-Smith, Elizabeth A.; Niemeyer, Debra M.; Prusaczyk, W. Keith; Rappold, Joseph F.; Rassmussen, Todd; Rentas, Francisco; Ross, James; Thompson, Christopher; Tucker, Leo D.

In: Shock, Vol. 39, No. 2, 02.2013, p. 121-126.

Research output: Contribution to journalArticle

Pusateri, AE, Weiskopf, RB, Bebarta, V, Butler, F, Cestero, RF, Chaudry, IH, Deal, V, Dorlac, WC, Gerhardt, RT, Given, MB, Hansen, DR, Hoots, WK, Klein, HG, MacDonald, VW, Mattox, KL, Michael, RA, Mogford, J, Montcalm-Smith, EA, Niemeyer, DM, Prusaczyk, WK, Rappold, JF, Rassmussen, T, Rentas, F, Ross, J, Thompson, C & Tucker, LD 2013, 'Tranexamic acid and trauma: Current status and knowledge gaps with recommended research priorities', Shock, vol. 39, no. 2, pp. 121-126. https://doi.org/10.1097/SHK.0b013e318280409a
Pusateri AE, Weiskopf RB, Bebarta V, Butler F, Cestero RF, Chaudry IH et al. Tranexamic acid and trauma: Current status and knowledge gaps with recommended research priorities. Shock. 2013 Feb;39(2):121-126. https://doi.org/10.1097/SHK.0b013e318280409a
Pusateri, Anthony E. ; Weiskopf, Richard B. ; Bebarta, Vikhyat ; Butler, Frank ; Cestero, Ramon F. ; Chaudry, Irshad H. ; Deal, Virgil ; Dorlac, Warren C. ; Gerhardt, Robert T. ; Given, Michael B. ; Hansen, Dan R. ; Hoots, W. Keith ; Klein, Harvey G. ; MacDonald, Victor W. ; Mattox, Kenneth L. ; Michael, Rodney A. ; Mogford, Jon ; Montcalm-Smith, Elizabeth A. ; Niemeyer, Debra M. ; Prusaczyk, W. Keith ; Rappold, Joseph F. ; Rassmussen, Todd ; Rentas, Francisco ; Ross, James ; Thompson, Christopher ; Tucker, Leo D. / Tranexamic acid and trauma : Current status and knowledge gaps with recommended research priorities. In: Shock. 2013 ; Vol. 39, No. 2. pp. 121-126.
@article{2b450749d46b4a4fa2fd71e2350e487a,
title = "Tranexamic acid and trauma: Current status and knowledge gaps with recommended research priorities",
abstract = "A recent large civilian randomized controlled trial on the use of tranexamic acid (TXA) for trauma reported important survival benefits. Subsequently, successful use of TXA for combat casualties in Afghanistan was also reported. As a result of these promising studies, there has been growing interest in the use of TXA for trauma. Potential adverse effects of TXA have also been reported. A US Department of Defense committee conducted a review and assessment of knowledge gaps and research requirements regarding the use of TXA for the treatment of casualties that have experienced traumatic hemorrhage. We present identified knowledge gaps and associated research priorities. We believe that important knowledge gaps exist and that a targeted, prioritized research effort will contribute to the refinement of practice guidelines over time.",
keywords = "efficacy, research requirements, safety, Tranexamic acid, trauma",
author = "Pusateri, {Anthony E.} and Weiskopf, {Richard B.} and Vikhyat Bebarta and Frank Butler and Cestero, {Ramon F.} and Chaudry, {Irshad H.} and Virgil Deal and Dorlac, {Warren C.} and Gerhardt, {Robert T.} and Given, {Michael B.} and Hansen, {Dan R.} and Hoots, {W. Keith} and Klein, {Harvey G.} and MacDonald, {Victor W.} and Mattox, {Kenneth L.} and Michael, {Rodney A.} and Jon Mogford and Montcalm-Smith, {Elizabeth A.} and Niemeyer, {Debra M.} and Prusaczyk, {W. Keith} and Rappold, {Joseph F.} and Todd Rassmussen and Francisco Rentas and James Ross and Christopher Thompson and Tucker, {Leo D.}",
year = "2013",
month = "2",
doi = "10.1097/SHK.0b013e318280409a",
language = "English (US)",
volume = "39",
pages = "121--126",
journal = "Shock",
issn = "1073-2322",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Tranexamic acid and trauma

T2 - Current status and knowledge gaps with recommended research priorities

AU - Pusateri, Anthony E.

AU - Weiskopf, Richard B.

AU - Bebarta, Vikhyat

AU - Butler, Frank

AU - Cestero, Ramon F.

AU - Chaudry, Irshad H.

AU - Deal, Virgil

AU - Dorlac, Warren C.

AU - Gerhardt, Robert T.

AU - Given, Michael B.

AU - Hansen, Dan R.

AU - Hoots, W. Keith

AU - Klein, Harvey G.

AU - MacDonald, Victor W.

AU - Mattox, Kenneth L.

AU - Michael, Rodney A.

AU - Mogford, Jon

AU - Montcalm-Smith, Elizabeth A.

AU - Niemeyer, Debra M.

AU - Prusaczyk, W. Keith

AU - Rappold, Joseph F.

AU - Rassmussen, Todd

AU - Rentas, Francisco

AU - Ross, James

AU - Thompson, Christopher

AU - Tucker, Leo D.

PY - 2013/2

Y1 - 2013/2

N2 - A recent large civilian randomized controlled trial on the use of tranexamic acid (TXA) for trauma reported important survival benefits. Subsequently, successful use of TXA for combat casualties in Afghanistan was also reported. As a result of these promising studies, there has been growing interest in the use of TXA for trauma. Potential adverse effects of TXA have also been reported. A US Department of Defense committee conducted a review and assessment of knowledge gaps and research requirements regarding the use of TXA for the treatment of casualties that have experienced traumatic hemorrhage. We present identified knowledge gaps and associated research priorities. We believe that important knowledge gaps exist and that a targeted, prioritized research effort will contribute to the refinement of practice guidelines over time.

AB - A recent large civilian randomized controlled trial on the use of tranexamic acid (TXA) for trauma reported important survival benefits. Subsequently, successful use of TXA for combat casualties in Afghanistan was also reported. As a result of these promising studies, there has been growing interest in the use of TXA for trauma. Potential adverse effects of TXA have also been reported. A US Department of Defense committee conducted a review and assessment of knowledge gaps and research requirements regarding the use of TXA for the treatment of casualties that have experienced traumatic hemorrhage. We present identified knowledge gaps and associated research priorities. We believe that important knowledge gaps exist and that a targeted, prioritized research effort will contribute to the refinement of practice guidelines over time.

KW - efficacy

KW - research requirements

KW - safety

KW - Tranexamic acid

KW - trauma

UR - http://www.scopus.com/inward/record.url?scp=84872973390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872973390&partnerID=8YFLogxK

U2 - 10.1097/SHK.0b013e318280409a

DO - 10.1097/SHK.0b013e318280409a

M3 - Article

C2 - 23222525

AN - SCOPUS:84872973390

VL - 39

SP - 121

EP - 126

JO - Shock

JF - Shock

SN - 1073-2322

IS - 2

ER -